BAKER BIOTECH CAPITAL II GP LLC Insider Trading $VPHM VIROPHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for BAKER BIOTECH CAPITAL II GP LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BAKER BIOTECH CAPITAL II GP LLC. BAKER BIOTECH CAPITAL II GP LLC is 10% Owner in NEUROGEN CORP ($NRGN) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
BAKER BIOTECH CAPITAL II GP LLC in VIROPHARMA INC
Trading Symbol: VPHMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BAKER BIOTECH CAPITAL II GP LLC: 10% Owner
Holdings: 193 shares
Latest Transaction: Apr 22 2005
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BAKER BIOTECH CAPITAL II GP LLC in VIROPHARMA INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, NRGN, SGEN, GEVA, VPHM
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 109.15 | 395,000 | 43,114,250 | 1,201,000 | |
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 109.15 | 268,000 | 29,252,200 | 806,000 | |
Apr 22 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 93,000 | 232,500 | 4,967,000 | |
Apr 18 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 63,000 | 157,500 | 4,874,000 | |
Apr 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 109.15 | 538,000 | 58,722,700 | 538,000 | |
Apr 12 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 139,000 | 347,500 | 4,811,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 31,000 | 77,500 | 4,213,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 139,000 | 347,500 | 4,672,000 | |
Apr 08 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 320,000 | 800,000 | 4,533,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 303,000 | 757,500 | 4,182,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 137,000 | 342,500 | 3,879,000 | |
Mar 02 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 344,000 | 860,000 | 3,742,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 10,000 | 25,000 | 91,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 29,000 | 72,500 | 81,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Option Exercise | P | 2.50 | 14,000 | 35,000 | 52,000 | |
Feb 14 2005 | VPHM | VIROPHARMA INC | BAKER BIOTECH CAPITAL II GP LL ... | 10% Owner | Buy | P | 3.02 | 193 | 583 | 193 | 0 to 193 |
Page: 1